Andrei Barbulescu

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Rheumatoid Arthritis

Placebo Controlled

Disease Activity

Top Venues

Clinical pharmacology and therapeutics

Rheumatology (Oxford, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Andrei Barbulescu, Johan Askling, Saedis Saevarsdottir, Seoyoung C Kim, Thomas Frisell
Combined Conventional Synthetic Disease Modifying Therapy vs. Infliximab for Rheumatoid Arthritis: Emulating a Randomized Trial in Observational Data. Clinical pharmacology and therapeutics 112 (4) (2022)
Andrei Barbulescu, Johan Askling, Katerina Chatzidionysiou, Helena Forsblad-d'Elia, Alf Kastbom, Ulf Lindström, Carl Turesson, Thomas Frisell
Effectiveness of baricitinib and tofacitinib compared with bDMARDs in RA: results from a cohort study using nationwide Swedish register data. Rheumatology (Oxford, England) 61 (10) (2022)
Andrei Barbulescu, Bénédicte Delcoigne, Johan Askling, Thomas Frisell
Gastrointestinal perforations in patients with rheumatoid arthritis treated with biological disease-modifying antirheumatic drugs in Sweden: a nationwide cohort study. RMD open 6 (2) (2021)